84 related articles for article (PubMed ID: 6972191)
1. [Indicator method of determining the beta-lactamase-inhibiting activity of various compounds].
Ivanitskaia LP; Nikishina VG
Antibiotiki; 1981 Apr; 26(4):259-64. PubMed ID: 6972191
[TBL] [Abstract][Full Text] [Related]
2. [Determination of the beta-lactamase-inhibiting capacity of different compounds by using a penicillinase-forming strain of Staphylococcus aureus 5A].
Nikishina VG; Ivanitskaia LP; Bibikova MV
Antibiotiki; 1981 Oct; 26(10):735-40. PubMed ID: 6975597
[TBL] [Abstract][Full Text] [Related]
3. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
Dinçer I; Ergin A; Kocagöz T
Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094
[TBL] [Abstract][Full Text] [Related]
4. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
5. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
6. [Penicillinase from B. licheniformis. Determination of the ionization constants of the enzymatic hydrolysis products of beta-lactam antibiotics].
Satarova DE; Nys PS; Korchagin VB; Savitskaia EM
Antibiotiki; 1984 Jan; 29(1):14-9. PubMed ID: 6607709
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing the inactivation of aminoglycosides by beta-lactams.
Flournoy DJ
Methods Find Exp Clin Pharmacol; 1979 Oct; 1(4):233-8. PubMed ID: 317880
[TBL] [Abstract][Full Text] [Related]
10. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
Campos M; Alarcón MA; González H; Sánchez R
Microbios; 1993; 76(308):171-9. PubMed ID: 8302198
[TBL] [Abstract][Full Text] [Related]
11. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic properties of beta-lactamase inhibitors.
de la Pena A; Derendorf H
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):63-75. PubMed ID: 10082170
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.
Li C; Nicolau DP; Lister PD; Quintiliani R; Nightingale CH
J Antimicrob Chemother; 2004 Feb; 53(2):297-304. PubMed ID: 14729755
[TBL] [Abstract][Full Text] [Related]
14. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
Prabhakaran K; Harris EB; Randhawa B; Hastings RC
Microbios; 1995; 81(328):177-85. PubMed ID: 7752957
[TBL] [Abstract][Full Text] [Related]
15. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.
Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H
Int J Pediatr Otorhinolaryngol; 2005 Apr; 69(4):479-85. PubMed ID: 15763284
[TBL] [Abstract][Full Text] [Related]
16. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
[TBL] [Abstract][Full Text] [Related]
17. Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains.
Nagy E; Szóke I; Gacs M; Csiszár K
Acta Microbiol Immunol Hung; 1995; 42(3):287-99. PubMed ID: 8548202
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of beta-lactams on human IFN-gamma activity.
Brooks BM; Hart CA; Coleman JW
J Antimicrob Chemother; 2005 Dec; 56(6):1122-5. PubMed ID: 16239287
[TBL] [Abstract][Full Text] [Related]
19. [beta-Lactamase inhibition as 1 of the ways of overcoming resistance to beta-lactam antibiotics].
Prokopenko VM; Tereshin IM
Antibiotiki; 1979 Nov; 24(11):867-73. PubMed ID: 389155
[No Abstract] [Full Text] [Related]
20. [Reactions of derivatives of beta-lactam antibiotics with non-antibacterial biological activity].
Gunda T
Acta Pharm Hung; 2002; 72(4):223-30. PubMed ID: 12812042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
